Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A role for Wnt signalling in self-renewal of haematopoietic stem cells.

Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL.

Nature. 2003 May 22;423(6938):409-14. Epub 2003 Apr 27.

PMID:
12717450
2.

Biology of hematopoietic stem cells and progenitors: implications for clinical application.

Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, Shizuru JA, Weissman IL.

Annu Rev Immunol. 2003;21:759-806. Epub 2002 Dec 17. Review.

PMID:
12615892
3.

Developmental plasticity of lymphoid progenitors.

Prohaska SS, Scherer DC, Weissman IL, Kondo M.

Semin Immunol. 2002 Dec;14(6):377-84. Review.

PMID:
12457610
4.
5.

The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L.

Nat Med. 2001 Sep;7(9):1052-6.

PMID:
11533710
6.

Lymphocyte development from hematopoietic stem cells.

Kondo M, Scherer DC, King AG, Manz MG, Weissman IL.

Curr Opin Genet Dev. 2001 Oct;11(5):520-6. Review.

PMID:
11532393
7.

Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.

Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, Sugamura K, Weissman IL.

Nature. 2000 Sep 21;407(6802):383-6.

PMID:
11014194
8.

Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.

Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L.

J Immunol. 1999 Sep 1;163(5):2373-7.

9.

Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.

Hong S, Scherer DC, Singh N, Mendiratta SK, Serizawa I, Koezuka Y, Van Kaer L.

Immunol Rev. 1999 Jun;169:31-44. Review.

PMID:
10450506
10.

Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45.

Zhang J, Liu X, Scherer DC, van Kaer L, Wang X, Xu M.

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12480-5.

11.

Transcription factor NF-kappaB regulates inducible Oct-2 gene expression in precursor B lymphocytes.

Bendall HH, Scherer DC, Edson CR, Ballard DW, Oltz EM.

J Biol Chem. 1997 Nov 14;272(46):28826-8.

12.

Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB.

Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW.

J Exp Med. 1997 Jun 2;185(11):1897-907.

13.

Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes.

Scherer DC, Brockman JA, Bendall HH, Zhang GM, Ballard DW, Oltz EM.

Immunity. 1996 Dec;5(6):563-74.

14.

Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.

McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, Ballard DW.

Mol Cell Biol. 1996 May;16(5):2083-90.

15.

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11259-63.

16.

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation.

Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW.

Mol Cell Biol. 1995 May;15(5):2809-18.

17.
18.

Supplemental Content

Loading ...
Support Center